Correction: Inability of granule polarization by NK cells defines tumor resistance and can be overcome by CAR or ADCC mediated targeting

Código QR

Correction: Inability of granule polarization by NK cells defines tumor resistance and can be overcome by CAR or ADCC mediated targeting

Guardado en:

Detalles Bibliográficos
Formato:	article
Lenguaje:	EN
Publicado:	BMJ Publishing Group 2021
Materias:	Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Acceso en línea:	https://doaj.org/article/df218bd6280e4292b87ff353a9599502
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Inability of granule polarization by NK cells defines tumor resistance and can be overcome by CAR or ADCC mediated targeting
por: Torsten Tonn, et al.
Publicado: (2021)

Novel TLR 7/8 agonists for improving NK cell mediated antibody-dependent cellular cytotoxicity (ADCC)
por: Vidhi Khanna, et al.
Publicado: (2021)

How Can We Engineer CAR T Cells to Overcome Resistance?
por: Glover M, et al.
Publicado: (2021)

Horses for Courses in the Era of CARs: Advancing CAR T and CAR NK Cell Therapies
por: Sergey Kulemzin, et al.
Publicado: (2021)

Current Perspectives on “Off-The-Shelf” Allogeneic NK and CAR-NK Cell Therapies
por: Erica L. Heipertz, et al.
Publicado: (2021)

ADCC-mediating non-neutralizing antibodies can exert immune pressure in early HIV-1 infection.
por: Dieter Mielke, et al.
Publicado: (2021)

ADCC-mediating non-neutralizing antibodies can exert immune pressure in early HIV-1 infection
por: Dieter Mielke, et al.
Publicado: (2021)

The Race of CAR Therapies: CAR-NK Cells for Fighting B-Cell Hematological Cancers
por: Lara Herrera, et al.
Publicado: (2021)

Overcoming Microalgae Harvesting Barrier by Activated Algae Granules
por: Olga Tiron, et al.
Publicado: (2017)

Targeted integration of EpCAM-specific CAR in human induced pluripotent stem cells and their differentiation into NK cells
por: Shin Yi Tang, et al.
Publicado: (2021)

Production of human CAR-NK cells with lentiviral vectors and functional assessment in vitro
por: Ana L. Portillo, et al.
Publicado: (2021)

Enhanced CAR-T activity against established tumors by polarizing human T cells to secrete interleukin-9
por: Lintao Liu, et al.
Publicado: (2020)

CAR-T: a potential gene carrier targeting solid tumor immune microenvironment
por: Minjie Wang, et al.
Publicado: (2021)

MAIT cells regulate NK cell-mediated tumor immunity
por: Emma V. Petley, et al.
Publicado: (2021)

Inability to Culture <named-content content-type="genus-species">Pneumocystis jirovecii</named-content>
por: Yueqin Liu, et al.
Publicado: (2018)

Is perceived inability to procreate associated with life satisfaction? Evidence from a German panel study
por: Julia McQuillan, et al.
Publicado: (2022)

HIV-1 Envelope Glycoproteins Proteolytic Cleavage Protects Infected Cells from ADCC Mediated by Plasma from Infected Individuals
por: Jérémie Prévost, et al.
Publicado: (2021)

NK Cells Can Preferentially Target Prostate Cancer Stem-like Cells via the TRAIL/DR5 Signaling Pathway
por: Taiga Seki, et al.
Publicado: (2021)

HIV-specific antibodies capable of ADCC are common in breastmilk and are associated with reduced risk of transmission in women with high viral loads.
por: Jennifer Mabuka, et al.
Publicado: (2012)

CAR T Cell Therapy’s Potential for Pediatric Brain Tumors
por: Pauline Thomas, et al.
Publicado: (2021)

Engineered CAR-Macrophages as Adoptive Immunotherapies for Solid Tumors
por: Christopher Sloas, et al.
Publicado: (2021)

FGF2 alters macrophage polarization, tumour immunity and growth and can be targeted during radiotherapy
por: Jae Hong Im, et al.
Publicado: (2020)

The Biological Role and Therapeutic Potential of NK Cells in Hematological and Solid Tumors
por: Rodion A. Velichinskii, et al.
Publicado: (2021)

Mating can initiate stable RNA silencing that overcomes epigenetic recovery
por: Sindhuja Devanapally, et al.
Publicado: (2021)

Engineering the chloroplast targeted malarial vaccine antigens in Chlamydomonas starch granules.
por: David Dauvillée, et al.
Publicado: (2010)

Reply to Liu et al., “Inability To Culture <named-content content-type="genus-species">Pneumocystis jirovecii</named-content>”
por: Verena Schildgen, et al.
Publicado: (2018)

Targetable vulnerabilities in T- and NK-cell lymphomas identified through preclinical models
por: Samuel Y. Ng, et al.
Publicado: (2018)

CXCR5 CAR-T cells simultaneously target B cell non-Hodgkin’s lymphoma and tumor-supportive follicular T helper cells
por: Mario Bunse, et al.
Publicado: (2021)

Formulation and Evaluation of Tablets Compressed from Granules Prepared by Thermoplastic Granulation
por: Kľoc D., et al.
Publicado: (2021)

Targeting monoamine oxidase A-regulated tumor-associated macrophage polarization for cancer immunotherapy
por: Yu-Chen Wang, et al.
Publicado: (2021)

Introduced species that overcome life history tradeoffs can cause native extinctions
por: Jane A. Catford, et al.
Publicado: (2018)

Post-stroke fatigue: A factor associated with inability to return to work in patients <60 years-A 1-year follow-up.
por: Nicole Anna Rutkowski, et al.
Publicado: (2021)

Emerging Approaches for Solid Tumor Treatment Using CAR-T Cell Therapy
por: Hyunmin Chung, et al.
Publicado: (2021)

NK-like T cells and plasma cytokines, but not anti-viral serology, define immune fingerprints of resilience and mild disability in exceptional aging.
por: Abbe N Vallejo, et al.
Publicado: (2011)

Overcoming the obstacles of current photodynamic therapy in tumors using nanoparticles
por: Donghyun Lee, et al.
Publicado: (2022)

Unifying heterogeneous expression data to predict targets for CAR-T cell therapy
por: Patrick Schreiner, et al.
Publicado: (2021)

Innovation in services and the internationalization of services SMEs: challenges and the policy spheres in which they can be overcome
por: Rodríguez, Luisa
Publicado: (2018)

Targeting IFNα to tumor by anti-PD-L1 creates feedforward antitumor responses to overcome checkpoint blockade resistance
por: Yong Liang, et al.
Publicado: (2018)

The Impact of NK Cell-Based Therapeutics for the Treatment of Lung Cancer for Biologics: Targets and Therapy
por: Hamilton G, et al.
Publicado: (2021)

Resistance is futile: overcoming resistance to targeted therapies in lung adenocarcinoma
por: Dana S. Neel, et al.
Publicado: (2017)